We are excited to announce the launch of a new Patient Area on the VANGUARD website. While we have previously addressed common patient inquiries through an official letter available on our Outreach page, we have taken a step further. The
The latest research from the VANGUARD project has been featured on the EU research platform together with another EU-funded HemAcure project, highlighting their significant impact on medical science. The HemAcure study on haemophilia A treatment was supported by the VANGUARD
The VANGUARD consortium is proud to join the World Health Organization in commemorating World Health Day 2024 on April 7. This year’s theme, ‘My Health, My Right,’ champions the fundamental right to health services and quality living conditions for everyone
The VANGUARD project is currently in its 52nd month of research and has made progress in all its work packages. Specifically, the research outcomes have resulted in a significant number of dissemination and communication activities, exceeding initial expectations. To date,
On January 27-28, the VANGUARD general assembly took place in Innsbruck, Austria. Nineteen participants representing the consortium’s nine project partners gathered for a two-day program consisting of project updates, planning sessions, and discussions. The meeting was kindly organized by the
A new publication on Regulatory Challenges at the Intersection of Cellular and Medical Device Therapies in Europe: The Case of the Bioartificial Pancreas in Law, Technology and Humans. Abstract Regenerative medicine solutions for type 1 diabetes are a rapidly developing
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement no. 874700